The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells
Abstract
Background Apoptosis and other forms of cell death have been intensively investigated in the past years to explain the mode of action of synthetic anticancer drugs and natural products. Recently, a new form of cell death emerged, which was termed ferroptosis, because it depends on intracellular iron. Here, the role of genes involved in iron metabolism and homeostasis for the cytotoxicity of ten artemisinin derivatives have been systematically investigated.Material and methods Log10IC50 values of 10 artemisinin derivatives (artesunate, artemether, arteether, artenimol, artemisitene, arteanuin B, another monomeric artemisinin derivative and three artemisinin dimer molecules) were correlated to the microarray-based mRNA expression of 30 iron-related genes in 60 cell lines of the National Cancer Institute (NCI, USA) as determined in 218 different microarray hybridization experiments. The effect of desferoxamine and ferrostatin-1 on the cytotoxicity of artenimol of CCRF-CEM cells was determined by resazurin assays. The mRNA expression of TFRC was exemplarily validated by immunohistochemical detection of transferrin receptor protein expression.Results The mRNA expression of 20 genes represented by 59 different cDNA clones significantly correlated to the log10IC50 values for the artemisinins, including genes encoding transferrin (TF), transferrin receptors 1 and 2 (TFRC, TFR2), cerulopasmin (CP), lactoferrin (LTF) and others. The ferroptosis inhibitor ferrostatin-1 and the iron chelator deferoxamine led to a significantly reduced cytotoxicity of artenimol, indicating ferroptosis as cell death mode.Conclusion The numerous iron-related genes, whose expression correlated with the response to artemisinin derivatives speak in factor for the relevance of iron for the cytotoxic activity of these compounds. Treatment with ferroptosis-inducing agents such as artemisinin derivatives represents an attractive strategy for cancer therapy. Pre-therapeutic determination of iron-related genes may indicate tumor sensitivity to artemisinins. Ferroptosis induced by artemisinin-type drugs deserve further investigation for individualized tumor therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, artemisinin derivatives have been reported to induce iron-dependent cell death, and specifically ferroptosis”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [84]
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Monks, A. P., Scudiero, D. A., Skehan, P., Shoemaker, R. H., Paull, K. D., Vistica, D. T., Hose, C. D., Langley, J. W., Cronise, P., Vaigro-Wolff, A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.757 · Cited by 3,305
Alley, M. C., Scudiero, D. A., Monks, A. P., Hursey, M. L., Czerwiński, M., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H., & Boyd, M. R. (1988) · PubMed · Cited by 3,082
The role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
A gene expression database for the molecular pharmacology of cancer
Scherf, U., Ross, D. T., Waltham, M. C., Smith, L. H., Lee, J. K., Tanabe, L. K., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., et al. (2000) · Nature Genetics · doi:10.1038/73439 · Cited by 1,450
The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
Tu, Y. (2011) · Nature Medicine · doi:10.1038/nm.2471 · Cited by 1,397
Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K., Rosenberg, P. A., Lo, D. C., Weinberg, J. M., Linkermann, A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411006a · Cited by 1,146
Reinhold, W. C., Sunshine, M., Liu, H., Varma, S., Kohn, K. W., Morris, J., Doroshow, J., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1370 · Cited by 887
Apoptosis and cancer: the genesis of a research field
Cotter, T. G. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2663 · Cited by 783
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Krishna, 2014, A randomized, double-blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer, EBioMedicine, 2014, 1
- Whitney, 1995, Transferrin receptor expression in nonsmall cell lung cancer, Histopathol. Clin. Correl. Cancer, 76, 20
Cited by
Sorted by citations
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Ferroptosis: Death by Lipid Peroxidation
Yang, W. S., & Stockwell, B. R. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.014 · Cited by 3,088
Broadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,967
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Berghe, T. V. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,498
Ferroptosis: machinery and regulation
Chen, X., Li, J., Kang, R., Klionsky, D. J., & Tang, D. (2021) · Autophagy · doi:10.1080/15548627.2020.1810918 · Cited by 2,099
Role of GPX4 in ferroptosis and its pharmacological implication
Seibt, T. M., Proneth, B., & Conrad, M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.014 · Cited by 1,520
Ferroptosis: Mechanisms and links with diseases
Yan, H.-F., Zou, T., Tuo, Q.-Z., Xu, S., Li, H., Belaidi, A. A., & Lei, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00428-9 · Cited by 1,471
Iron Metabolism in Ferroptosis
Chen, X., Yu, C., Kang, R., & Tang, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590226 · Cited by 1,001
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 1,056
Reactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A. U., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 918
Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases
Yu, Y., Yan, Y., Niu, F., Wang, Y., Chen, X., Su, G., Liu, Y., Zhao, X., Lü, Q., Liu, P., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00579-w · Cited by 808
FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation
Gaschler, M. M., Andia, A. A., Liu, H., Csuka, J. M., Hurlocker, B., Vaiana, C. A., Heindel, D. W., Zuckerman, D. S., Bos, P. H., Reznik, E., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0031-6 · Cited by 750
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Shen, Z., Song, J., Yung, B. C., Zhou, Z., Wu, A., & Chen, X. S. (2018) · Advanced Materials · doi:10.1002/adma.201704007 · Cited by 744
Ferroptosis, a new form of cell death, and its relationships with tumourous diseases
Yu, H., Guo, P., Xie, X., Wang, Y., & Chen, G. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13008 · Cited by 718
Molecular mechanisms of ferroptosis and its role in cancer therapy
Xu, T., Ding, W., Ji, X., Ao, X., Liu, Y., Yu, W., & Wang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14511 · Cited by 644
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
Efferth, T. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.009 · Cited by 632
Self-citationFerroptosis, a novel pharmacological mechanism of anti-cancer drugs
Su, Y., Zhao, B., Zhou, L., Zhang, Z., Shen, Y., Lv, H., AlQudsy, L. H. H., & Shang, P. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.015 · Cited by 586
Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death
Battaglia, A. M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F. S., & Biamonte, F. (2020) · Cells · doi:10.3390/cells9061505 · Cited by 586
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Luo, H., Vong, C. T., Chen, H., Gao, Y., Lyu, P., Qiu, L., Zhao, M., Liu, Q., Cheng, Z., Zou, J., et al. (2019) · Chinese Medicine · doi:10.1186/s13020-019-0270-9 · Cited by 569
Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
Chen, G., Benthani, F. A., Wu, J., Liang, D., Bian, Z., & Jiang, X. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0352-3 · Cited by 518
Iron and cancer: recent insights
Manz, D. H., Blanchette, N. L., Paul, B. T., Torti, F. M., & Torti, S. V. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13008 · Cited by 507
Du, J., Wang, T., Li, Y., Zhou, Y., Wang, X., Yu, X., Ren, X., An, Y., Wu, Y., Sun, W., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.011 · Cited by 487
Ferroptosis and Its Role in Diverse Brain Diseases
Weiland, A., Wang, Y., Wu, W., Lan, X., Han, X., Li, Q., & Wang, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1403-3 · Cited by 473
The Role of Ferroptosis in Cancer Development and Treatment Response
Lu, B., Chen, X. B., Ying, M. D., He, Q. J., Cao, J., & Yang, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00992 · Cited by 444
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells
Adedoyin, O. O., Boddu, R., Traylor, A., Lever, J. M., Bolisetty, S., George, J. F., & Agarwal, A. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00044.2017 · Cited by 372
Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway
Kong, Z., Liu, R., & Cheng, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.030 · Cited by 364
Chen, Y., Mi, Y., Zhang, X., Ma, Q., Song, Y., Zhang, L., Wang, D., Xing, J., Hou, B., Li, H., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1413-7 · Cited by 319
Lin, R., Zhang, Z., Chen, L., Zhou, Y., Zou, P., Feng, C., Wang, L., & Liang, G. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.033 · Cited by 294
Ferritinophagy/ferroptosis: Iron‐related newcomers in human diseases
Tang, M., Chen, Z., Wu, D., & Chen, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26954 · Cited by 291
Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action
Wong, Y. K., Xu, C., Kalesh, K., He, Y., Lin, Q., Wong, W. S. F., Shen, H., & Wang, J. (2017) · Medicinal Research Reviews · doi:10.1002/med.21446 · Cited by 244
Yu, H., Yang, C., Lei, J., Guo, S., Chen, R., Li, K., Qu, F., Tao, K. X., Fu, Y., Luo, F., et al. (2019) · Oncology Reports · doi:10.3892/or.2019.7189 · Cited by 225
Tang, B., Zhu, J., Li, J., Fan, K. C., Gao, Y., Cheng, S., Kong, C., Zheng, L., Wu, F., Weng, Q., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00663-1 · Cited by 219
Artemisinin, the Magic Drug Discovered from Traditional Chinese Medicine
Wang, J., Xu, C., Wong, Y. K., Li, Y., Liao, F., Jiang, T., & Tu, Y. (2018) · Engineering · doi:10.1016/j.eng.2018.11.011 · Cited by 228
Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT
Wang, Z., Ding, Y., Wang, X., Lu, S., Wang, C., He, C. H., Wang, L., Piao, M., Chi, G., Luo, Y., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.021 · Cited by 211
Branched-chain amino acid aminotransferase 2 regulates ferroptotic cell death in cancer cells
Wang, K., Zhang, Z., Tsai, H., Liu, Y., Gao, J., Wang, M., Song, L., Cao, X., Xu, Z., Chen, H., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00644-4 · Cited by 209
Targeting ferroptosis in breast cancer
Li, Z., Chen, L., Chen, C., Zhou, Y., Hu, D., Yang, J., Chen, Y., Zhuo, W., Mao, M., Zhang, X., et al. (2020) · Biomarker Research · doi:10.1186/s40364-020-00230-3 · Cited by 208
Artemisia annua, a Traditional Plant Brought to Light
Septembre‐Malaterre, A., Rakoto, M. L., Marodon, C., Bedoui, Y., Nakab, J., Simon, E., Hoarau, L., Savriama, S., Strasberg, D., Guiraud, P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144986 · Cited by 190
Five-Membered Ring Peroxide Selectively Initiates Ferroptosis in Cancer Cells
Abrams, R. P. M., Carroll, W. L., & Woerpel, K. A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00900 · Cited by 193
Targeting Programmed Cell Death Using Small‐Molecule Compounds to Improve Potential Cancer Therapy
Ke, B., Tian, M., Li, J., Liu, B., & He, G. (2016) · Medicinal Research Reviews · doi:10.1002/med.21398 · Cited by 190
Nanomaterial-induced ferroptosis for cancer specific therapy
Liu, M., Liu, B., Liu, Q., Du, K., Wang, Z., & He, N. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.12.015 · Cited by 180
Iron and leukemia: new insights for future treatments
Wang, F., Lv, H., Zhao, B., Zhou, L., Wang, S., Luo, J., Liu, J., & Shang, P. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1397-3 · Cited by 172
The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach
Xia, X., Fan, X., Zhao, M., & Zhu, P. (2019) · Current Gene Therapy · doi:10.2174/1566523219666190628152137 · Cited by 161
Zhou, Y., Shen, Y., Chen, C., Sui, X., Yang, J., Wang, L., & Zhou, J. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0158 · Cited by 157
Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential
Lei, X. L., Zhao, G. Y., Guo, R., & Cui, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956361 · Cited by 156
Li, Y., Liu, Y., Wu, P., Tian, Y., Liu, B., Wang, J., Bihl, J. C., & Shi, H. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00850-1 · Cited by 142
Markowitsch, S. D., Schupp, P., Lauckner, J., Vakhrusheva, O., Slade, K. S., Mager, R., Efferth, T., Haferkamp, A., & Juengel, E. (2020) · Cancers · doi:10.3390/cancers12113150 · Cited by 129
Self-citationRecent progress on targeting ferroptosis for cancer therapy
Xu, G., Wang, H., Li, X., Huang, R., & Luo, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114584 · Cited by 121
Feng, J., Wang, J., Wang, Y., Huang, X., Shao, T., Deng, X., Cao, Y., Zhou, M., & Zhao, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.898657 · Cited by 127
Cancer combination therapies with artemisinin-type drugs
Efferth, T. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.019 · Cited by 122
Self-citationXu, Q., Zhao, B., Ye, Y., Li, Y., Zhang, Y., Xiong, X., & Gu, L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02137-8 · Cited by 119
Ferroptosis: An emerging therapeutic opportunity for cancer
Wang, L., Chen, X., & Yan, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.09.005 · Cited by 119
Zhao, F., Vakhrusheva, O., Markowitsch, S. D., Slade, K. S., Tsaur, I., Cinatl, J. J., Michaelis, M., Efferth, T., Haferkamp, A., & Juengel, E. (2020) · Cells · doi:10.3390/cells9122643 · Cited by 119
Self-citationKoeberle, S. C., Kipp, A. P., Stuppner, H., & Koeberle, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21933 · Cited by 117
Antischistosomal activity of artemisinin derivatives in vivo and in patients
Saeed, M. E. M., Krishna, S., Greten, H. J., Kremsner, P. G., & Efferth, T. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.017 · Cited by 111
Self-citationWang, J., Zhang, J., Shi, Y. P., Xu, C., Zhang, C., Wong, Y. K., Lee, Y. M., Krishna, S., He, Y., Lim, T. K., et al. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00156 · Cited by 108
Non-apoptotic cell death in malignant tumor cells and natural compounds
Ye, J., Zhang, R., Wu, F., Zhai, L., Wang, K., Xiao, M., Xie, T., & Sui, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.061 · Cited by 103
Nutritional and Metabolic Control of Ferroptosis
Mishima, E., & Conrad, M. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062320-114541 · Cited by 107
Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy
Zhu, S., Yu, Q., Huo, C., Li, Y., He, L., Ran, B., Chen, J., Li, Y., & Liu, W. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200121124404 · Cited by 104
Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer
Zhou, L., Zhao, B., Zhang, L., Wang, S., Dong, D., Lv, H., & Shang, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051545 · Cited by 102
Arsenite induces testicular oxidative stress in vivo and in vitro leading to ferroptosis
Meng, P., Zhang, S., Jiang, X., Cheng, S., Zhang, J., Cao, X., Qin, X., Zou, Z., & Chen, C. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110360 · Cited by 103
Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
Li, B., Yang, L., Peng, X., Fan, Q., Wei, S., Yang, S., Li, X., Jin, H., Wu, B., Huang, M., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110710 · Cited by 104
Ferroptosis in Carcinoma: Regulatory Mechanisms and New Method for Cancer Therapy
Shi, Z., Fan, Z.-W., Chen, Y., Xie, X., Jiang, W., Wang, W., Qiu, Y., & Bai, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s232852 · Cited by 101
Yu, L., Zhang, L., Peng, C., Zhang, S., Chen, S., Qian, X., Luo, W., Dan, Q., Ren, Y., Li, Y., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.016 · Cited by 97
Yang, K., Zeng, L., Yuan, X., Wang, S., Ge, A., Xu, H., Zeng, J., & Ge, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113611 · Cited by 98
Ferroptosis in life: To be or not to be
Xu, L., Liu, Y., Chen, X., Zhong, H., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114241 · Cited by 100
Antitumor Research on Artemisinin and Its Bioactive Derivatives
Zhang, Y., Xu, G., Zhang, S., Wang, D., Prabha, P. S., & Zuo, Z. (2018) · Natural Products and Bioprospecting · doi:10.1007/s13659-018-0162-1 · Cited by 96
Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?
Li, Z., Li, Q., Wu, J., Wang, M., & Yu, J. (2016) · Molecules · doi:10.3390/molecules21101331 · Cited by 95
Wang, Z., Li, M., Liu, Y., Qiao, Z., Bai, T., Yang, L., & Liu, B. (2021) · Oncology Reports · doi:10.3892/or.2021.8191 · Cited by 95
Nunes, J. J., Pandey, S. K., Yadav, A., Goel, S., & Ateeq, B. (2017) · Neoplasia · doi:10.1016/j.neo.2017.02.002 · Cited by 95
Zhu, H., Huang, Z., Chen, G.-Q., Sheng, F., & Zheng, Y.-S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.070 · Cited by 91
New drugs are not enough‑drug repositioning in oncology: An update
Armando, R., Mengual G�mez, D., & Gomez, D. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4966 · Cited by 90
Ferroptosis: Cancer Stem Cells Rely on Iron until “to Die for” It
Cosialls, E., Elhage, R., Santos, L. D., Gong, C., Mehrpour, M., & Hamaï, A. (2021) · Cells · doi:10.3390/cells10112981 · Cited by 94
Ebrahimi, N., Adelian, S., Shakerian, S., Afshinpour, M., Chaleshtori, S. R., Ravari, N. R., Rezaei‐Tazangi, F., Beiranvand, S., Hamblin, M. R., & Aref, A. R. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.01.006 · Cited by 91
Li, Y., Jin, C., Shen, M., Wang, Z., Tan, S., Chen, A., Wang, S., Shao, J., Zhang, F., Zhang, Z., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.09.008 · Cited by 89
Mechanism of Ferroptosis: A Potential Target for Cardiovascular Diseases Treatment
Ju, J., Song, Y., & Wang, K. (2021) · Aging and Disease · doi:10.14336/ad.2020.0323 · Cited by 88
Regulation of ferroptosis by bioactive phytochemicals: Implications for medical nutritional therapy
Zheng, K., Dong, Y., Yang, R., Liang, Y., Wu, H., & He, Z. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105580 · Cited by 89
Necroptosis: A new way of dying?
Hanson, B. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1210732 · Cited by 92
Bao, Z., Hua, L., Ye, Y., Wang, D., Li, C., Xie, Q. M., Wakimoto, H., Gong, Y., & Ji, J. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab114 · Cited by 89
Targeting ferroptosis: Paving new roads for drug design and discovery
Gu, Y., Li, Y., Wang, J., Zhang, L., Zhang, J., & Wang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.115015 · Cited by 88
Zhou, P., Zhang, S., Wang, M., & Zhou, J. F. (2023) · Biomolecules · doi:10.3390/biom13050820 · Cited by 85
Zhang, T., Deng, W., Deng, Y., Liu, Y., Xiao, S., Luo, Y., Xiang, W., & He, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114706 · Cited by 85
Xie, B., & Guo, Y. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00483-3 · Cited by 80
Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma
Michaelsen, F.-W., Saeed, M. E. M., Schwarzkopf, J., & Efferth, T. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.11.001 · Cited by 81
Self-citationFerroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future
Fang, W., Xie, S., & Deng, W. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09853-w · Cited by 82
Non-canonical programmed cell death mechanisms triggered by natural compounds
Diederich, M. F., & Cerella, C. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.06.001 · Cited by 80
Xu, C., Zhang, H., Mu, L., & Yang, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.529881 · Cited by 82
Mbaveng, A. T., CHi Godloves, F. R. U., Bonsou, I. N., Abdelfatah, S., Tamfu, A. N., Yeboah, E. M. O., Kuete, V., & Efferth, T. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153261 · Cited by 77
Self-citationInduction of programmed necrosis: A novel anti-cancer strategy for natural compounds
Yu, J. Z., Zhong, B., Xiao, Q., Du, L., Hou, Y., Sun, H., Lu, J.-J., & Chen, X. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107593 · Cited by 76
Wu, Y., Chen, H., Xuan, N., Zhou, L., Wu, Y., Zhu, C., Li, M., Weng, Q., Shen, J., Zhang, H., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-214764 · Cited by 76
Medicinal and mechanistic overview of artemisinin in the treatment of human diseases
Posadino, A. M., Giordo, R., Pintus, G., Mohammed, S. A., Orhan, İ. E., Fokou, P. V. T., Sharopov, F. S., Adetunji, C. O., Gulsunoglu‐Konuskan, Z., Ydyrys, A., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114866 · Cited by 75
The role of iron homeostasis and iron-mediated ROS in cancer.
Ying, J., Lu, Z.-B., Fu, L., Tong, Y., Wang, Z., Li, W., & Mou, X. (2021) · PubMed · Cited by 85
Recent Advances in the Therapeutic Efficacy of Artesunate
Ruwizhi, N., Maseko, R. B., & Aderibigbe, B. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030504 · Cited by 73
Hu, Y., Guo, N., Yang, T., Yan, J., Wang, W., & Li, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1458143 · Cited by 73
Natural Products as Inducers of Non-Canonical Cell Death: A Weapon against Cancer
Greco, G., Catanzaro, E., & Fimognari, C. (2021) · Cancers · doi:10.3390/cancers13020304 · Cited by 70
Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications
Yin, L., Liu, P., Jin, Y., Ning, Z., Yang, Y., & Gao, H. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114861 · Cited by 66
Aloe-emodin as drug candidate for cancer therapy
Özenver, N., Saeed, M. E. M., Demirezer, L. Ö., & Efferth, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24880 · Cited by 67
Self-citationFerroptosis is Involved in Hypoxic-ischemic Brain Damage in Neonatal Rats
Lin, W., Zhang, T., Zheng, J., Zhou, Y., Lin, Z., & Fu, X. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.02.013 · Cited by 64
Artesunate: A review of its therapeutic insights in respiratory diseases
Zhang, J., Li, Y., Wan, J., Zhang, M., Li, C., & Lin, J. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154259 · Cited by 64
Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies
Zhao, Y., Huang, Z., & Peng, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.743006 · Cited by 62
Metadata
- Authors
- Ooko, E., Saeed, M. E. M., Kadioglu, O., Sarvi, S., Colak, M., Elmasaoudi, K., Janah, R., Greten, H. J., & Efferth, T.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Universidade do Porto (PT)
- Corresponding author
- Efferth, Thomas
- Venue
- Phytomedicine
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 22
- Issue
- 11
- Pages
- 1045-1054
- ISSN
- 0944-7113 (ISSN-L)
- OpenAlex
- W1156477804
- Cited by
- 387
- References
- 54
- Citations by year
- 2026: 23 · 2025: 32 · 2024: 37 · 2023: 48 · 2022: 60 · 2021: 57 · 2020: 46 · 2019: 27 · 2018: 23 · 2017: 14 · 2016: 16 · 2015: 3
- FWCI
- 14.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Phytomedicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- artemisinin derivatives, ferroptosis, iron metabolism, ferrostatin-1, deferoxamine, transferrin receptor, ceruloplasmin, lactoferrin, tumor cell killing, anticancer natural products, CCRF-CEM cells, precision oncology
- MeSH terms
- Artesunate, Artemether, Cyclohexylamines, Deferoxamine, Humans, Iron, Phenylenediamines, Molecular Structure, Gene Expression Regulation, Neoplastic, Cell Death, Apoptosis, Inhibitory Concentration 50, Oligonucleotide Array Sequence Analysis, Artemisinins, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review